Journal of Ginseng Research

The Korean Society of Ginseng (고려인삼학회)
권호 표지
DOI QR코드

DOI QR Code

Antiarrhythmic effects of ginsenoside Rg2 on calcium chloride-induced arrhythmias without oral toxicity

  • Gou, Dongxia (School of Life Sciences, Northeast Normal University) ;
  • Pei, Xuejing (School of Life Sciences, Northeast Normal University) ;
  • Wang, Jiao (School of Life Sciences, Northeast Normal University) ;
  • Wang, Yue (School of Life Sciences, Northeast Normal University) ;
  • Hu, Chenxing (School of Life Sciences, Northeast Normal University) ;
  • Song, Chengcheng (School of Life Sciences, Northeast Normal University) ;
  • Cui, Sisi (School of Life Sciences, Northeast Normal University) ;
  • Zhou, Yifa (School of Life Sciences, Northeast Normal University)
  • Received : 2018.11.23
  • Accepted : 2019.06.17
  • Published : 2020.09.15
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Malignant arrhythmias require drug therapy. However, most of the currently available antiarrhythmic drugs have significant side effects. Ginsenoside Rg2 exhibits excellent cardioprotective effects and appears to be a promising candidate for cardiovascular drug development. So far, the oral toxicity and antiarrhythmic effects of Rg2 have not been evaluated. Methods: Acute oral toxicity of Rg2 was assessed by the Limit Test method in mice. Subchronic oral toxicity was determined by repeated dose 28-day toxicity study in rats. Antiarrhythmic activities of Rg2 were evaluated in calcium chloride-induced arrhythmic rats. Antiarrhythmic mechanism of Rg2 was investigated in arrhythmic rats and H9c2 cardiomyocytes. Results: The results of toxicity studies indicated that Rg2 exhibited no single-dose (10 g/kg) acute oral toxicity. And 28-day repeated dose treatment with Rg2 (1.75, 3.5 and 5 g/kg/d) demonstrated minimal, if any, subchronic toxicity. Serum biochemical examination showed that total cholesterol in the high-dose cohort was dramatically decreased, whereas prothrombin time was increased at Day 28, suggesting that Rg2 might regulate lipid metabolism and have a potential anticoagulant effect. Moreover, pretreatment with Rg2 showed antiarrhythmic effects on the rat model of calcium chloride induced arrhythmia, in terms of the reduced duration time, mortality, and incidence of malignant arrhythmias. The antiarrhythmic mechanism of Rg2 might be the inhibition of calcium influx through L-type calcium channels by suppressing the phosphorylation of Ca2+/calmodulin-dependent protein kinase II. Conclusion: Our findings support the development of Rg2 as a promising antiarrhythmic drug with fewer side effects for clinical use.

Keywords

References

  1. Peng L, Sun S, Xie LH, Wicks SM, Xie JT. Ginsenoside Re: pharmacological effects on cardiovascular system. Cardiovasc Ther 2012;30:e183-8. https://doi.org/10.1111/j.1755-5922.2011.00271.x
  2. Jin KH, Pitna K, Young SC. A comprehensive review of the therapeutic and pharmacological effects of ginseng and ginsenosides in central nervous system. J Ginseng Res 2013;37:8-29. https://doi.org/10.5142/jgr.2013.37.8
  3. Kang S, Park SJ, Lee AY, Huang J, Chung HY, Im DS. Ginsenoside Rg3 promotes inflammation resolution through M2 macrophage polarization. J Ginseng Res 2018;42:68-74. https://doi.org/10.1016/j.jgr.2016.12.012
  4. Li W, Yin JY, Cong Z, Liu Y, Zhang Y, Li Y, Meng Q. Anti-colon carcinoma cell activity of ginsenosides from the acid hydrolysate of Panax ginseng. Chem Nat Compd 2013;48:1017-20. https://doi.org/10.1007/s10600-013-0453-z
  5. Zhang G, Liu A, Zhou Y, San X, Jin T, Jin Y. Panax ginseng ginsenoside-Rg2 protects memory impairment via anti-apoptosis in a rat model with vascular dementia. J Ethnopharmacol 2008;115:441-8. https://doi.org/10.1016/j.jep.2007.10.026
  6. Cui J, Wang J, Zheng M, Gou D, Liu C, Zhou Y. Ginsenoside Rg2 protects PC12 cells against ${\beta}$-amyloid 25-35 -induced apoptosis via the phosphoinositide 3-kinase/Akt pathway. Chemico-Biological Interactions 2017;275:152-61. https://doi.org/10.1016/j.cbi.2017.07.021
  7. Fan Y, Wang N, Rocchi A, Zhang W, Vassar R, Zhou Y, He C. Identification of natural products with neuronal and metabolic benefits through autophagy induction. Autophagy 2017;13:41-56. https://doi.org/10.1080/15548627.2016.1240855
  8. Fu W, Xu H, Yu X, Lyu C, Tian Y, Guo M. 20(S)-Ginsenoside Rg2 attenuates myocardial ischemia/reperfusion injury by reducing oxidative stress and inflammation: role of SIRT1. RSC Adv 2018;20:23947-62.
  9. Fu W, Sui D, Yu X, Gou D, Zhou Y, Xu H. Protective effects of ginsenoside Rg2 against $H_2O_2$-induced injury and apoptosis in H9c2 cells. Int J Clin Exp Med 2015;8:19938-47.
  10. Strandberg TE, Nieminen T. Cardiovascular disease. In: Regina RW, Katrin S, Maria CP, editors. Learning geriatric medicine. Springer; 2018. p. 123-36.
  11. Singh SN, Patrick J, Patrick J. Antiarrhythmic drugs. Curr Treat Options Cardiovasc Med 2004;6:357-64. https://doi.org/10.1007/s11936-004-0019-2
  12. Liu C, Huang Y. Chinese herbal medicines on cardiovascular diseases and the mechanism of action. Front Pharmacol 2016;7:1-21.
  13. Gao J, Hu Y, Meng Y, Meng F, Guo X, Wang N, Wei M, Zhou Y. Simple and efficient preparation of ginsenoside (S)-Rg2 from ginsenoside Re by biotransformation with Cellulosimicrobium sp. 21. Biocatal Biotransformation 2015;33:51-60. https://doi.org/10.3109/10242422.2015.1018192
  14. Yang S, Lee SW, Kim YO, Sohn S, Kim YC. HPLC-based metabolic profiling and quality control of leaves of different Panax species. J Ginseng Res 2013;37:248-53. https://doi.org/10.5142/jgr.2013.37.248
  15. OECD/OECDE: test No. 407: repeated dose 28-day oral toxicity study in rodents. OECD Guide Test Chem 2008:1-13.
  16. Wu X, Qi L, Chen S. Protective effects of ginsenoside-Ｒg2 on ventricular remodeling induced by isoproterenol in rats. Chin J Appl Physiol 2018;34(3):201-3.
  17. Grimaldi G, Maggi CA, Meli A. Influence of some psychotropic agents on CaCl2-induced arrhythmias in the rat. J Pharm Pharmacol 1981;33:194. https://doi.org/10.1111/j.2042-7158.1981.tb13754.x
  18. Eichelbaum M, Birkel P, Grube E, Gutgemann U, Somogyi A. A comprehensive review of the therapeutic and pharmacological effects of ginseng and ginsenosides in central nervous system. J Mol Med 1980;18(5):919-26.
  19. Malinow MR, Batlle FF, Malamud B. Prevention of neurogenic ventricular arrhythmias in the rat by autonomic blocking drugs. AmJ Physiol 1953;175:8-10. https://doi.org/10.1152/ajplegacy.1953.175.1.8
  20. Grumbach L, Howard JW, Merrill VI. Factors related to the initiation of ventricular fibrillation in the isolated heart: effect of calcium and potassium. Circ Res 1954;2:452-9. https://doi.org/10.1161/01.RES.2.5.452
  21. Hudmon A, Schulman H, Kim J, Maltez JM, Tsien RW, Pitt GS. CaMKII tethers to L-type $Ca^{2+}$ channels, establishing a local and dedicated integrator of $Ca^{2+}$ signals for facilitation. J Cell Biol 2005;171(3):537-47. https://doi.org/10.1083/jcb.200505155
  22. Lu D, Liu J, Zhao W, Li P. Chronic toxicity of ginsenoside Re on Sprague-Dawley rats. J Ethnopharmacol 2012;144:656-63. https://doi.org/10.1016/j.jep.2012.10.007
  23. Yoo H-S, Jeong M-K, Cho C-K. General and genetic toxicology of enzymetreated ginseng extract. J Pharmacopuncture 2016;19:213-24. https://doi.org/10.3831/KPI.2016.19.022
  24. Bocan TMA, Mueller SB, Brown EQ, Lee P, Bocan MJ, Rea T, Pape ME. HMG-CoA reductase and ACAT inhibitors act synergistically to lower plasma cholesterol and limit atherosclerotic lesion development in the cholesterol-fed rabbit. Atherosclerosis 1998;139:21-3. https://doi.org/10.1016/S0021-9150(98)00046-X
  25. Lewington S, Clarke R. Combined effects of systolic blood pressure and total cholesterol on cardiovascular disease risk. Circulation 2005;112:3373-4. https://doi.org/10.1161/CIRCULATIONAHA.105.581934
  26. Lee M-S, Kim C-T, Kim I-H, Kim Y. Effects of Korean Red Ginseng extract on hepatic lipid accumulation in HepG2 cells. Biosci Biotechnol Biochem 2015;79:1-4. https://doi.org/10.1080/09168451.2014.952614
  27. Li CT, Wang HB, Xu BJ. A comparative study on anticoagulant activities of three Chinese herbal medicines from the genus Panax and anticoagulant activities of ginsenosides Rg1 and Rg2. Pharm Biol 2013;51:1077-80. https://doi.org/10.3109/13880209.2013.775164
  28. Trujillo TC, Nolan PE. Antiarrhythmic agents: drug interactions of clinical significance. Drug Saf An Int J Med Toxicol Drug Exp 2000;23:509-32. https://doi.org/10.2165/00002018-200023060-00003
  29. Chen C, Zhang H. Protective effect of ginsenoside Re on isoproterenol induced ventricular arrhythmia in rabbits. Chin J Comtemp Pediatr 2009;11:384-8.
  30. Bai C, Takahashi K, Masumiya H, Sawanoboti T, Furukawa T. Nitric oxidedependent modulation of the delayed rectifier $K^+$ current and the L-type $Ca^{2+}$ current by ginsenoside Re, an ingredient of Panax ginseng, in Guinea-pig cardiomyocytes. Br J Pharm 2004;142:567-75. https://doi.org/10.1038/sj.bjp.0705814
  31. Pitt GS. Calmodulin and CaMKII as molecular switches for cardiac ion channels. Card Electrophysiol Cell Bedside 2014;73(4):189-95. https://doi.org/10.1016/B978-1-4557-2856-5.00019-4

Cited by

  1. Ginsenoside CK-loaded self-nanomicellizing solid dispersion with enhanced solubility and oral bioavailability vol.25, pp.9, 2020, https://doi.org/10.1080/10837450.2020.1800730